{"id":2838,"date":"2012-12-10T07:23:06","date_gmt":"2012-12-10T07:23:06","guid":{"rendered":"http:\/\/www.neurodegenerationresearch.eu\/2014\/09\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/"},"modified":"2014-09-22T09:13:59","modified_gmt":"2014-09-22T09:13:59","slug":"25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2","status":"publish","type":"post","link":"https:\/\/neurodegenerationresearch.eu\/nb\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/","title":{"rendered":"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases"},"content":{"rendered":"<p><strong>JPND is inviting calls for proposals from research teams across Europe to increase understanding of the factors that put people at risk of developing neurodegenerative diseases such as Alzheimer\u0092s and also to evaluate health and social care strategies for people living with these debilitating illnesses.<\/strong><\/p>\n<p>\u0091The incidence of Neurodegenerative diseases such as Alzheimer\u0092s and Parkinson\u0092s is exploding due to aging populations, which are creating huge social, economic and healthcare impacts across the world\u0092 according to Professor Philippe Amouyel, Chair of the JPND Management Board.&amp;nbsp;&amp;nbsp; \u0091With this in mind, European Member States have identified these two areas of greatest need for targeted investment in order to delay progression or prevent ND and to improve the care provided for those living with these diseases and their carers\u0092. Professor Amouyel added \u0091This investment is part of a series of annual JPND funding initiatives over the next three years, aimed at addressing priority areas identified in our European Research Strategy.&amp;nbsp; This year\u0092s calls will see approximately 25 million euro made available to applicants from over 20 countries. <\/p>\n<p>According to Professor Thomas Gasser, University of T\u00fcbingen and Chair of the JPND Scientific Advisory Board, \u0091these actions are an important step towards realising the ultimate goal of JPND \u0096 finding causes, developing cures, and identifying appropriate ways to care for those with neurodegenerative diseases\u0092. <\/p>\n<p>The following neurodegenerative diseases are included for both calls: <\/p>\n<ul>\n<li>Alzheimer\u0092s disease and other dementias <\/li>\n<li>Parkinson\u0092s disease and PD?related disorders <\/li>\n<li>Prion disease <\/li>\n<li>Motor neurone diseases <\/li>\n<li>Huntington\u0092s disease <\/li>\n<li>Spinocerebellar ataxia (SCA) <\/li>\n<li>Spinal muscular atrophy (SMA)<\/li>\n<\/ul>\n<p><strong>Call 1: Assessing risk factors for ND<br \/><\/strong>The first call for proposals aims to attract international teams of researchers who will explore the different processes at work in normal aging versus neurodegenerative aging and determine what role genetic and environmental factors can play.&amp;nbsp; Factors such as family history, gender, stress levels, nutrition and others, can affect an individual\u0092s risk, and provide protection from, or even resilience to, neurodegenerative diseases.&amp;nbsp;&amp;nbsp; However, it is likely that a combination of factors are involved, so a critical step will be to establish the relationship between genetic, epigenetic, environmental and social factors and their relative importance in order to identify those factors that can be changed or modified.&amp;nbsp;  <\/p>\n<p>Modern research techniques have allowed researchers to create models of risk and protective factors.&amp;nbsp; The aim of this call is to engage researchers to use these techniques and apply them to neurodegenerative diseases. The ultimate aim will be to use the knowledge generated to develop strategies that can delay or even prevent these diseases. <\/p>\n<p><strong>Call 2: Evaluating health and social care policies, strategies and interventions for ND<br \/><\/strong>It is widely accepted that better integration and coordination of approaches to health and social care across Europe would help to reduce costs and improve the quality of care for patients with ND and their carers.&amp;nbsp; In order to tackle this issue, the first step has to be an assessment of the strengths and weaknesses of formal (e.g. hospitals) and informal (family- and home-based) care. Establishing what works best will create a firm foundation to support new initiatives that tackle inequality and inefficiency and build equal, fair and efficient health and social care systems for ND. <\/p>\n<p>This call asks research teams to assess and compare the policies, strategies and interventions related to neurodegenerative disease care, with regard to quality, access and cost-effectiveness. Examples of areas to be evaluated include care pathways, psychosocial interventions, end-of-life strategies, and educational programmes that benefit not just persons with neurodegenerative diseases, but also their carers and families.&amp;nbsp; The call will also seek proposals to improve the various outcome measures currently used to assess the impact of healthcare and social care interventions on the quality of life of patients and carers \u0096 for example inclusion of the patients\u0092 and carers\u0092 perspective.&amp;nbsp;  <\/p>\n<p>More information on the participating countries in both calls, in addition to specific grant practicalities is available at <link initiatives\/2012-joint-transnational-calls\/open-calls\/>https:\/\/www.neurodegenerationresearch.eu\/initiatives\/2012-joint-transnational-calls\/open-calls\/<\/link><\/p>\n<p>Media enquiries should be directed to:<br \/>Derick Mitchell<link dmitchell@hrb.ie>dmitchell@hrb.ie<\/link>+353 1 2345103<\/p>\n","protected":false},"excerpt":{"rendered":"<p>JPND is inviting calls for proposals from research teams across [&hellip;]<\/p>\n<a href=\"https:\/\/neurodegenerationresearch.eu\/nb\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/\">View Post<\/a>","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[68],"tags":[],"class_list":["post-2838","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases - JPND Neurodegenerative Disease Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer\u0092s-and-other-neurodegenerative-diseases-2\/\" \/>\n<meta property=\"og:locale\" content=\"nb_NO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases - JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"og:description\" content=\"JPND is inviting calls for proposals from research teams across [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer\u0092s-and-other-neurodegenerative-diseases-2\/\" \/>\n<meta property=\"og:site_name\" content=\"JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"article:published_time\" content=\"2012-12-10T07:23:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-09-22T09:13:59+00:00\" \/>\n<meta name=\"author\" content=\"jpnd\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:site\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet av\" \/>\n\t<meta name=\"twitter:data1\" content=\"jpnd\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ansl. lesetid\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/de\\\/2012\\\/12\\\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/de\\\/2012\\\/12\\\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\\\/\"},\"author\":{\"name\":\"jpnd\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\"},\"headline\":\"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases\",\"datePublished\":\"2012-12-10T07:23:06+00:00\",\"dateModified\":\"2014-09-22T09:13:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/de\\\/2012\\\/12\\\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\\\/\"},\"wordCount\":701,\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"articleSection\":[\"JPND Press Releases\"],\"inLanguage\":\"nb-NO\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/de\\\/2012\\\/12\\\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\\\/\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/de\\\/2012\\\/12\\\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\\\/\",\"name\":\"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases - JPND Neurodegenerative Disease Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\"},\"datePublished\":\"2012-12-10T07:23:06+00:00\",\"dateModified\":\"2014-09-22T09:13:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/de\\\/2012\\\/12\\\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\\\/#breadcrumb\"},\"inLanguage\":\"nb-NO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neurodegenerationresearch.eu\\\/de\\\/2012\\\/12\\\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/de\\\/2012\\\/12\\\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"name\":\"JPND Neurodegenerative Disease Research\",\"description\":\"Neurodegenerative Disease Research\",\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nb-NO\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\",\"name\":\"JPND\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"width\":248,\"height\":129,\"caption\":\"JPND\"},\"image\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/JPNDeurope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\",\"name\":\"jpnd\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"caption\":\"jpnd\"},\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/nb\\\/author\\\/jpnd\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases - JPND Neurodegenerative Disease Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer\u0092s-and-other-neurodegenerative-diseases-2\/","og_locale":"nb_NO","og_type":"article","og_title":"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases - JPND Neurodegenerative Disease Research","og_description":"JPND is inviting calls for proposals from research teams across [&hellip;]","og_url":"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer\u0092s-and-other-neurodegenerative-diseases-2\/","og_site_name":"JPND Neurodegenerative Disease Research","article_published_time":"2012-12-10T07:23:06+00:00","article_modified_time":"2014-09-22T09:13:59+00:00","author":"jpnd","twitter_card":"summary_large_image","twitter_creator":"@JPNDeurope","twitter_site":"@JPNDeurope","twitter_misc":{"Skrevet av":"jpnd","Ansl. lesetid":"3 minutter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/#article","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/"},"author":{"name":"jpnd","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a"},"headline":"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases","datePublished":"2012-12-10T07:23:06+00:00","dateModified":"2014-09-22T09:13:59+00:00","mainEntityOfPage":{"@id":"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/"},"wordCount":701,"publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"articleSection":["JPND Press Releases"],"inLanguage":"nb-NO"},{"@type":"WebPage","@id":"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/","url":"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/","name":"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases - JPND Neurodegenerative Disease Research","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/#website"},"datePublished":"2012-12-10T07:23:06+00:00","dateModified":"2014-09-22T09:13:59+00:00","breadcrumb":{"@id":"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/#breadcrumb"},"inLanguage":"nb-NO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/neurodegenerationresearch.eu\/de\/2012\/12\/25-million-euro-boost-for-research-into-alzheimer%c2%92s-and-other-neurodegenerative-diseases-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neurodegenerationresearch.eu\/"},{"@type":"ListItem","position":2,"name":"25 million euro boost for research into Alzheimer\u0092s and other neurodegenerative diseases"}]},{"@type":"WebSite","@id":"https:\/\/neurodegenerationresearch.eu\/#website","url":"https:\/\/neurodegenerationresearch.eu\/","name":"JPND Neurodegenerative Disease Research","description":"Neurodegenerative Disease Research","publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neurodegenerationresearch.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nb-NO"},{"@type":"Organization","@id":"https:\/\/neurodegenerationresearch.eu\/#organization","name":"JPND","url":"https:\/\/neurodegenerationresearch.eu\/","logo":{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","contentUrl":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","width":248,"height":129,"caption":"JPND"},"image":{"@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/JPNDeurope"]},{"@type":"Person","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a","name":"jpnd","image":{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","caption":"jpnd"},"url":"https:\/\/neurodegenerationresearch.eu\/nb\/author\/jpnd\/"}]}},"_links":{"self":[{"href":"https:\/\/neurodegenerationresearch.eu\/nb\/wp-json\/wp\/v2\/posts\/2838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neurodegenerationresearch.eu\/nb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurodegenerationresearch.eu\/nb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/nb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/nb\/wp-json\/wp\/v2\/comments?post=2838"}],"version-history":[{"count":0,"href":"https:\/\/neurodegenerationresearch.eu\/nb\/wp-json\/wp\/v2\/posts\/2838\/revisions"}],"wp:attachment":[{"href":"https:\/\/neurodegenerationresearch.eu\/nb\/wp-json\/wp\/v2\/media?parent=2838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/nb\/wp-json\/wp\/v2\/categories?post=2838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/nb\/wp-json\/wp\/v2\/tags?post=2838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}